4.7 Article

Characterization of US population levels of urinary methylcarbamoyl mercapturic acid, a metabolite of N,N-dimethylformamide and methyl isocyanate, in the National Health and Nutrition Examination Survey (NHANES) 2005-2006 and 2011-2016

Journal

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
Volume 28, Issue 13, Pages 16781-16791

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s11356-020-12135-7

Keywords

N; N-Dimethylformamide; Methyl isocyanate; N-acetyl-S-(N-methylcarbamoyl)-L-cysteine; Methylcarbamoyl mercapturic acid; Tobacco smoke exposure; Volatile organic compounds

Funding

  1. Intramural CDC HHS [CC999999] Funding Source: Medline

Ask authors/readers for more resources

Methylcarbamoyl mercapturic acid (MCAMA) is a urinary biomarker that can indicate human exposure to harmful compounds such as N,N-dimethylformamide and methyl isocyanate. This study found a strong association between smoking and higher levels of urinary MCAMA, highlighting the importance of tobacco smoke exposure assessment.
Methylcarbamoyl mercapturic acid (MCAMA, N-acetyl-S-(N-methylcarbamoyl)-L-cysteine) is a urinary metabolite of N,N-dimethylformamide and methyl isocyanate, which are volatile organic compounds that are harmful to humans. N,N-dimethylformamide exposure causes liver damage, and methyl isocyanate inhalation damages the lining of the respiratory tract, which can increase risk of chronic obstructive pulmonary disease and asthma. This study characterizes urinary MCAMA levels in the US population and explores associations of MCAMA concentrations with select demographic and environmental factors. We used liquid chromatography tandem mass spectrometry to measure MCAMA in urine collected from study participants >= 12 years old (N = 8272) as part of the National Health and Nutrition Examination Survey 2005-2006 and 2011-2016. We produced multiple regression models with MCAMA concentrations as the dependent variable and sex, age, fasting time, race/ethnicity, diet, and cigarette smoking as independent variables. Cigarette smokers and nonsmokers had median urinary MCAMA concentrations of 517 mu g/g creatinine and 127 mu g/g creatinine, respectively. Sample-weighted multiple regression analysis showed that MCAMA was positively associated with serum cotinine (p < 0.0001). Compared to non-exposed participants (serum cotinine <= 0.015 ng/mL), presumptive exposure to second-hand tobacco smoke (serum cotinine > 0.015-<= 10 ng/mL and 0 cigarettes smoked per day) was associated with 20% higher MCAMA (p < 0.0001). Additionally, smoking 1-10 cigarettes per day was associated with 261% higher MCAMA (p < 0.0001), smoking 11-20 cigarettes per day was associated with 357% higher MCAMA (p < 0.0001), and smoking > 20 cigarettes per day was associated with 416% higher MCAMA (p < 0.0001). These findings underscore the strong association of tobacco smoke exposure with urinary MCAMA biomarker levels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available